New Japanese Regenerative Medicine Legislation and Commercial … – GlobeNewswire (press release)
| GlobeNewswire (press release) 25, 2013 (GLOBE NEWSWIRE) — Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today gave an update on new legislation which provides a framework for accelerated approval of stem cell products in Japan, the world’s … Mesoblast lifted by Japan stem cell plansCommBank MyWealth |
